Hy2Care receives €6M EU funding for optimal cartilage repair

Geleen, 9 June 2022 – The European Commission has awarded Dutch medical device start-up Hy2Care €6 million in blended financing. This enables Hy2Care to complete its clinical studies and to obtain European market approval with its game-changing hydrogel for optimal cartilage repair. The company receives the financing via the European Innovation Council (EIC) Accelerator program.